Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen Cheng

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
International Journal of Epidemiology|February 20, 2026
New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort studyJiahui Qian, Sandrine Stepien, Allen Cheng, et al.
Antimicrobial Resistance and Infection Control|March 29, 2018
Vancomycin-resistant <i>Enterococcus faecium</i> sequence type 796 - rapid international dissemination of a new epidemic cloneAndrew A Mahony, Andrew H Buultjens, Susan A Ballard, et al.
Environment International|October 8, 2024
Towards integrated cross-sectoral surveillance of pathogens and antimicrobial resistance: Needs, approaches, and considerations for linking surveillance to actionRachael Lappan, Steven L Chown, Matthew French, et al.
Research Square|October 7, 2024
Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohortSheena Sullivan, Arseniy Khvorov, Louise Carolan, et al.
Communicable Diseases Intelligence (2018)|April 6, 2022
Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)Husna Begum, Dominic E Dwyer, Mark Holmes, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humansFatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.
Eclinicalmedicine|October 26, 2022
Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trialJames H McMahon, Jillian S Y Lau, Anna Coldham, et al.
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialDerek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
International Journal of Epidemiology|February 20, 2026
New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort studyJiahui Qian, Sandrine Stepien, Allen Cheng, et al.
Antimicrobial Resistance and Infection Control|March 29, 2018
Vancomycin-resistant <i>Enterococcus faecium</i> sequence type 796 - rapid international dissemination of a new epidemic cloneAndrew A Mahony, Andrew H Buultjens, Susan A Ballard, et al.
Environment International|October 8, 2024
Towards integrated cross-sectoral surveillance of pathogens and antimicrobial resistance: Needs, approaches, and considerations for linking surveillance to actionRachael Lappan, Steven L Chown, Matthew French, et al.
Research Square|October 7, 2024
Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohortSheena Sullivan, Arseniy Khvorov, Louise Carolan, et al.
Communicable Diseases Intelligence (2018)|April 6, 2022
Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)Husna Begum, Dominic E Dwyer, Mark Holmes, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humansFatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.
Eclinicalmedicine|October 26, 2022
Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trialJames H McMahon, Jillian S Y Lau, Anna Coldham, et al.
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialDerek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Pageof 12